Journal
JOURNAL OF CLINICAL MEDICINE
Volume 12, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/jcm12072512
Keywords
leadless pacemaker; Micra; atrioventricular synchronous pacing; atrioventricular synchrony; meta-analysis
Categories
Ask authors/readers for more resources
Leadless pacemakers with atrioventricular synchronous pacing demonstrate favorable safety and efficacy, as evidenced by several small-scale observational studies. This systematic review and meta-analysis evaluates the efficacy and safety of this new technology. The results show a high proportion of atrioventricular synchrony after implantation and a significant increase in cardiac output. The overall incidence of complications is low, indicating the potential for widespread adoption in clinical practice.
Leadless pacemakers with an atrioventricular synchrony algorithm represent a novel technology for patients qualified for VDD pacing. The current evidence of their performance is limited to several small-scale observational studies. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of this new technology. We systematically searched the PubMed, Embase, and Cochrane library databases from their inception to 12 September 2022. The primary efficacy outcome was atrioventricular synchrony after implantation, whereas the secondary efficacy outcome was the change in cardiac output represented by the left ventricular outflow tract velocity time integral (LVOT-VTI). The primary safety outcome was major complications related to the procedures and the algorithm. Means or mean differences with 95% confidence interval (95% CI) were combined using a random-effects model or a fixed-effects model. Finally, 8 published studies with 464 participants were included in the qualitative analysis. The pooled atrioventricular synchrony proportion was 78.9% (95% CI 71.9-86.0%), and a further meta-regression did not screen factors that contributed significantly to the heterogeneity. Additionally, a significant increase in atrioventricular synchrony of 11.3% (95% CI 7.0-15.7%, p < 0.01) was achieved in patients experiencing programming optimization. LVOT-VTI was significantly increased by 1.9 cm (95% CI 1.2-2.6, p < 0.01), compared with the VVI pacing mode. The overall incidence of complications was approximately 6.3%, with major complications related to the algorithm being extremely low. Overall, leadless pacemakers with atrioventricular synchronous pacing demonstrated favorable safety and efficacy. Future data on their long-term performance are required to facilitate their widespread adoption in clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available